scispace - formally typeset
H

Henry Johannes Greten

Researcher at University of Porto

Publications -  91
Citations -  2259

Henry Johannes Greten is an academic researcher from University of Porto. The author has contributed to research in topics: Acupuncture & Cancer. The author has an hindex of 23, co-authored 88 publications receiving 1779 citations. Previous affiliations of Henry Johannes Greten include Heidelberg University.

Papers
More filters
Journal ArticleDOI

Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells.

TL;DR: The numerous iron-related genes, whose expression correlated with the response to artemisinin derivatives speak in factor for the relevance of iron for the cytotoxic activity of these compounds.
Journal ArticleDOI

World Congress Integrative Medicine & Health 2017: Part one

Carolyn Ee, +776 more
TL;DR: This work is presented at the I1 World Congress for Integrative Medicine & Health 2017 a global forum for exploring the future of comprehensive patient care in Washington, DC.
Journal ArticleDOI

Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.

TL;DR: In this paper, a workflow of combined in silico methods (virtual drug screening, molecular docking and supervised machine learning algorithms) was applied to identify novel drug candidates against COVID-19.
Journal ArticleDOI

Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?

TL;DR: While CIPN has multiple mechanisms of neuronal degeneration, a combination of herbs or substances might deal with multiple targets for the aim of neuroprotection or neuroregeneration in CIPn.
Journal ArticleDOI

Antischistosomal activity of artemisinin derivatives in vivo and in patients.

TL;DR: Artemisinin-type drugs induced oxidative and metabolic stress leading to morphological damage and decreased fertility of the parasites, although artemether and artesunate have been investigated in numerous clinical trials, the poor quality has led to inconsistent results and has not provided convincing evidence on the therapeutic value against schistosomiasis.